Abstract
Purpose
Our purpose was to investigate the effect on the ovarian response of increasing the gonadotropin dose.
Methods
We analyzed retrospectively the in vitro fertilization data for patients who had two cycles of treatment, with a higher dose in cycle 2. The patients were stratified according to age, ovarian response, and gonadotropin dose in the first cycle. The main outcome measure was the number of follicles, eggs, and embryos and the peak estradiol (E2) level.
Results
The study included 244 patients. Patients in both age groups (n = 118, - <33 years; n = 126, > 33 years), low (n = 66) and intermediate (n = 145) responders, and patients who received < 225 IU folliclestimulating hormone (n = 175) in cycle I had a better response in cycle 2. However, the high responders (n = 33) and those who received 225 or 300 IU folliclestimulating hormone (n = 69) in cycle I showed a similar response in both cycles, except for a significantly higher E2 level in cycle 2.
Conclusions
Our results indicate that exceeding a daily dose of 300 IU is unrewarding.
Key words: gonadotropin dose, in vitro fertilization, ovarian response
Full Text
The Full Text of this article is available as a PDF (474.0 KB).
References
- 1.Lauffer N, DeCherney AH, Haseltine FP, Dumolin JC. The use of high-dose human menopausal gonadotrophin in an in vitro fertilisation program. Fertil Steril. 1982;38:734–741. doi: 10.1016/s0015-0282(16)47472-8. [DOI] [PubMed] [Google Scholar]
- 2.Jones HW, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, Veek L, Wilkes C, Witmyer J, Wortham JE, Wright G. The program for in vitro fertilisation at Norfolk. Fertil Steril. 1982;38:14–21. [PubMed] [Google Scholar]
- 3.Land JA, Yarmolinskaya MI, Dumoulin JC.M, Evans JH. Highdose human menopausal gonadotrophin stimulation in poor responders does not improve the in vitro fertilization outcome. Fertil Steril. 1996;65:961–965. doi: 10.1016/s0015-0282(16)58269-7. [DOI] [PubMed] [Google Scholar]
- 4.Lockwood GM, Pinkerton SM, Barlow DH. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod. 1995;10:293–298. doi: 10.1093/oxfordjournals.humrep.a135930. [DOI] [PubMed] [Google Scholar]
- 5.Gougeon A. Rate of follicular growth in the human ovary. In: Rolland R, Hall EV, Hillier SG, McNatty K, Schomaker J, editors. Follicular Maturation and Ovulation. Amsterdam: Excerpta Medica; 1982. pp. 155–163. [Google Scholar]
- 6.Hillier SG. Regulation of follicular oestrogen biosynthesis: A survey of current concepts. J Endocrinol. 1981;89:3P–18P. [PubMed] [Google Scholar]
- 7.Baird DT. A model for follicular selection and ovulation: Lessons from superovulation. J Steroid Biochem. 1987;27:15–23. doi: 10.1016/0022-4731(87)90289-5. [DOI] [PubMed] [Google Scholar]
- 8.Pantos C, Thornton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotrophin dose—Does the response really improve? Fertil Steril. 1990;53:436–439. doi: 10.1016/s0015-0282(16)53337-8. [DOI] [PubMed] [Google Scholar]